Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.

Roos-Weil D, Decaudin C, Armand M, Della-Valle V, Diop MK, Ghamlouch H, Ropars V, Hérate C, Lara D, Durot E, Haddad R, Mylonas E, Damm F, Pflumio F, Stoilova B, Metzner M, Elemento O, Dessen P, Camara-Clayette V, Cosset FL, Verhoeyen E, Leblond V, Ribrag V, Cornillet-Lefebvre P, Rameau P, Azar N, Charlotte F, Morel P, Charbonnier JB, Vyas P, Mercher T, Aoufouchi S, Droin N, Guillouf C, Nguyen-Khac F, Bernard OA.

Cancer Discov. 2019 Jun;9(6):796-811. doi: 10.1158/2159-8290.CD-18-0873. Epub 2019 Apr 24.

PMID:
31018969
2.

Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.

Desmots F, Roussel M, Pangault C, Llamas-Gutierrez F, Pastoret C, Guiheneuf E, Le Priol J, Camara-Clayette V, Caron G, Henry C, Belaud-Rotureau MA, Godmer P, Lamy T, Jardin F, Tarte K, Ribrag V, Fest T.

Clin Cancer Res. 2019 Jan 15;25(2):735-746. doi: 10.1158/1078-0432.CCR-18-1153. Epub 2018 Oct 22.

3.

Histone deacetylase inhibitor abexinostat affects chromatin organization and gene transcription in normal B cells and in mantle cell lymphoma.

Markozashvili D, Pichugin A, Barat A, Camara-Clayette V, Vasilyeva NV, Lelièvre H, Kraus-Berthier L, Depil S, Ribrag V, Vassetzky Y.

Gene. 2016 Apr 15;580(2):134-143. doi: 10.1016/j.gene.2016.01.017. Epub 2016 Jan 13.

PMID:
26774800
4.

Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma.

Allinne J, Pichugin A, Iarovaia O, Klibi M, Barat A, Zlotek-Zlotkiewicz E, Markozashvili D, Petrova N, Camara-Clayette V, Ioudinkova E, Wiels J, Razin SV, Ribrag V, Lipinski M, Vassetzky YS.

Blood. 2014 Mar 27;123(13):2044-53. doi: 10.1182/blood-2013-06-510511. Epub 2014 Jan 22.

5.

The NF-κB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samples.

Camara-Clayette V, Lecluse Y, Schrader C, Klapper W, Vainchenker W, Hermine O, Ribrag V.

Eur J Cancer. 2014 Jan;50(1):159-69. doi: 10.1016/j.ejca.2013.09.010. Epub 2013 Oct 14.

PMID:
24135685
6.

BMP7 expression correlates with secondary drug resistance in mantle cell lymphoma.

Camara-Clayette V, Koscielny S, Roux S, Lamy T, Bosq J, Bernard M, Fest T, Lazar V, Lenoir G, Ribrag V.

PLoS One. 2013 Sep 12;8(9):e73993. doi: 10.1371/journal.pone.0073993. eCollection 2013.

7.

Emerging agents for the treatment of mantle cell lymphoma.

Camara-Clayette V, Hermine O, Ribrag V.

Expert Rev Anticancer Ther. 2012 Sep;12(9):1205-15. doi: 10.1586/era.12.99. Review.

PMID:
23098120
8.

p38 Mitogen-activated protein kinase signaling, ERCC1 expression, and viability of lung cancer cells from never or light smoker patients.

Planchard D, Camara-Clayette V, Dorvault N, Soria JC, Fouret P.

Cancer. 2012 Oct 15;118(20):5015-25. doi: 10.1002/cncr.27510. Epub 2012 Mar 13.

9.

Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.

Bluteau D, Gilles L, Hilpert M, Antony-Debré I, James C, Debili N, Camara-Clayette V, Wagner-Ballon O, Cordette-Lagarde V, Robert T, Ripoche H, Gonin P, Swierczek S, Prchal J, Vainchenker W, Favier R, Raslova H.

Blood. 2011 Dec 8;118(24):6310-20. doi: 10.1182/blood-2010-12-325555. Epub 2011 Jul 1.

10.

Imaging of the distribution of (90)y-ibritumomab tiuxetan in bone marrow and comparison with pathology.

Coulot J, Camara-Clayette V, Ricard M, Lavielle F, Velasco V, Drusch F, Bosq J, Schlumberger M, Ribrag V.

Cancer Biother Radiopharm. 2007 Oct;22(5):665-71.

PMID:
17979569
11.

Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.

Rolland D, Camara-Clayette V, Barbarat A, Salles G, Coiffier B, Ribrag V, Thieblemont C.

Cancer Chemother Pharmacol. 2008 Apr;61(5):855-63. Epub 2007 Jul 18.

12.

Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments.

Lepelletier Y, Camara-Clayette V, Jin H, Hermant A, Coulon S, Dussiot M, Arcos-Fajardo M, Baude C, Canionni D, Delarue R, Brousse N, Benaroch P, Benhamou M, Ribrag V, Monteiro RC, Moura IC, Hermine O.

Cancer Res. 2007 Feb 1;67(3):1145-54.

13.

Quantitative Oct4 overproduction in mouse embryonic stem cells results in prolonged mesoderm commitment during hematopoietic differentiation in vitro.

Camara-Clayette V, Le Pesteur F, Vainchenker W, Sainteny F.

Stem Cells. 2006 Aug;24(8):1937-45. Epub 2006 May 11.

14.

Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells.

Garçon L, Rivat C, James C, Lacout C, Camara-Clayette V, Ugo V, Lecluse Y, Bennaceur-Griscelli A, Vainchenker W.

Blood. 2006 Sep 1;108(5):1551-4. Epub 2006 May 9.

15.

Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells.

Camara-Clayette V, Rahuel C, Lopez C, Hattab C, Verkarre V, Bertrand O, Cartron JP.

Biochem J. 2001 May 15;356(Pt 1):171-80.

16.

The E-box of the human glycophorin B promoter is involved in the erythroid-specific expression of the GPB gene.

Camara-Clayette V, Rahuel C, Bertrand O, Cartron JP.

Biochem Biophys Res Commun. 1999 Nov;265(1):170-6.

PMID:
10548509
17.

The repressor which binds the -75 GATA motif of the GPB promoter contains Ku70 as the DNA binding subunit.

Camara-Clayette V, Thomas D, Rahuel C, Barbey R, Cartron JP, Bertrand O.

Nucleic Acids Res. 1999 Apr 1;27(7):1656-63.

Supplemental Content

Loading ...
Support Center